Hunting Hill Global Capital’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Hunting Hill Global Capital’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,038	Closed	-$329K	–	153
2023 Q4	$329K	Buy	+1,038	New	+$202K	0.14%	81

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Hunting Hill Global Capital's KRTX Position: Q1 2024 in Review

Hunting Hill Global Capital sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,038 shares — an estimated $329K sold.

Hunting Hill Global Capital first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $329K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Hunting Hill Global Capital reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Hunting Hill Global Capital sold 1,038 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $329K.
Hunting Hill Global Capital first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Hunting Hill Global Capital's Karuna Therapeutics, Inc. Common Stock position peaked at $329K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Hunting Hill Global Capital's 13F filing for Q1 2024, filed 15 May 2024.